Font Size: a A A
Keyword [Allo-HSCT]
Result: 1 - 20 | Page: 1 of 6
1. Studies On Relationship Between GVHD And Tissue Distribution Kinetics Of T Lymphocytes And Their Subsets After Allo-HSCT In A Murine Model
2. Inhibition Of Graft-Versus-Host Disease By Indoleamine-gene Modified Dendritic Cells
3. 1.Study On Early Diagnosis Of Invasive Aspergilosis With Serum Galactomannan Detection In Patients With Hematological Disease 2.Invasive Fungal Infections After Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) And Related Risk Factors
4. Donor NK Cells And IL-15 Treatment Promoted Engraftment During Nonmyeloablative Allo-HSCT
5. GVHD Prediction Based On HLA Three-dimensional Structure Modeling
6. Research On Expression Of TCR Vβsubfamily T Clonal Cells After Allo-HSCT
7. The Role Of Th Subset Cells And Some Cytokines In The Pathogenesis Of Acute Graft-versus-host Disease After The Allogeneic Hematopoietic Stem Cell Transplantation
8. Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) For Hematologic Malignancies
9. An Experimental And Clinical Study Of CMV Infection After Allogeneic Hematopoietic Stem Cell Transplantation
10. Study On The Correlation Of FasL, Cranzyme B And Perforin Expressions By Quantitation-competitive RT-PCR With Acute GVHD After Allogeneic Stem Cell Transplantation
11. The Study Of Dendritic Cells After Allogeneic Hematopoietic Stem Cell Transplantation
12. Effect Of Plasma Exchange On Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
13. A Study On The Relationship Between CD4～+CD25～+T Cells And Acute GVHD After Allo-HSCT
14. Analysis Of Cellular Immunity Function Related To Graft-Versus-Host-Disease
15. Study On The Lysising Of Allo-reactional Donor NK Cells On The Recipient Leukemia Cells
16. The Study Of Immune Tolerance Induced By TReg Cells In Allogeneic Hematopoietic Stem Cell Transplantation
17. The Mechanism Of Engraftment Promotions By Marrow Mesenchymal Induced By Chemokine Receptors In ALLO-HSCT
18. Concentration Monitoring In Whole Blood, Clinical Application And Safety Evaluation Of Sirolimus In Allo-HSCT Patients
19. The Role Of STAT1 In Immune Tolerance Induction Of T Cells Form Allo-HSCT Donor Pretreated By G-CSF
20. Study In Pharmacokinetics And Clinical Relationship About Bu Taken In Two Ways By Allo-HSCT Patients
  <<First  <Prev  Next>  Last>>  Jump to